Our strategy

Focused on the opportunity: Growing earnings and improving returns

Our plan to grow earnings and improve returns brings together growth actions with transformation initiatives to drive improved performance. This approach is focused on growth and efficiency – with progress already evident and expected to continue.

We are taking deliberate steps to drive more consistent growth by sharpening our focus on innovation, improving the customer experience, maximising returns from investments and drive consistent growth in key markets, such as Beauty and Pharma.

We are encouraged by the strong progress being made in executing our transformation initiatives. By implementing permanent structural improvements, we are becoming a more efficient and resilient company. It’s about simplifying, modernising and standardising the way we do things across the business to make both the customer and employee experience a much better one.

Driving consistent growth

Refocus innovation

New ingredient development

We develop new ingredients to fulfil unmet needs, with sales of new ingredients increasing by 10% this year at constant currency. New launches included Kerabio K31, a patented biomimetic bond-builder for hair that enables brands to compete with market leaders in the hair repair market and has been sampled by 500 customers.

New markets for existing ingredients

We are optimising our existing ingredient range to meet the needs of particular regions, markets or customers. Projects included developing our existing range of more than 2,000 lipids for the Pharma generics market.

Customer co-creation

Our approach to customer co-creation leverages our ability to tailor individual ingredients and formulate multiple ingredients to meet specific customer requirements. The average pipeline value of customer co-creation projects increased by 12% in 2025, with projects including co-creating PEG-free variants of existing ingredients.